BlackRock’s Ocera Therapeutics OCRX Stock Holding History
Bought
Maintained
Sold
BlackRock's OCRX Position: Q4 2017 in Review
BlackRock sold out of Ocera Therapeutics (OCRX) in Q4 2017, closing a stake of 74,716 shares — an estimated $86K sold.
BlackRock first reported a position in OCRX in Q1 2017 and held it in 3 quarters. The position peaked at $88K in Q2 2017. 0 funds tracked by Wall St. Rank hold OCRX as of Q4 2017.
- BlackRock reported no remaining Ocera Therapeutics position as of Q4 2017 after selling out during the quarter.
- BlackRock sold 74,716 Ocera Therapeutics shares in Q4 2017, an estimated $86K.
- BlackRock first reported a position in Ocera Therapeutics in Q1 2017 and held it in 3 quarters.
- BlackRock's Ocera Therapeutics position peaked at $88K in Q2 2017.
- 0 funds tracked by Wall St. Rank held Ocera Therapeutics as of Q4 2017.
Based on BlackRock's 13F filing for Q4 2017, filed 9 Feb 2018.